Not admitted · Vague or promotional

Medication-series post of 2023-09-27 on risperidone (Janssen-Cilag/J&J, FDA-approved 1994). The author says risperidone and its metabolite paliperidone still have an important role in schizophrenia and bipolar disorder because of the many long-acting injectable formulations; he predicts those LAI drugs will be useful for a long time, while oral risperidone will not ('Nope').

No entity, observable event, benchmark or threshold can be written from the text and its immediate context. Slogans ('game changer', 'once-in-a-lifetime opportunity', 'favourite stock') and quantifiers with no countable set ('more', 'first', 'all') without a defined set.